Gary Christie

4.8k total citations · 2 hit papers
25 papers, 3.9k citations indexed

About

Gary Christie is a scholar working on Physiology, Molecular Biology and Oncology. According to data from OpenAlex, Gary Christie has authored 25 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 9 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Gary Christie's work include Alzheimer's disease research and treatments (10 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Protein Structure and Dynamics (3 papers). Gary Christie is often cited by papers focused on Alzheimer's disease research and treatments (10 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Protein Structure and Dynamics (3 papers). Gary Christie collaborates with scholars based in United Kingdom, United States and Canada. Gary Christie's co-authors include Eric Karran, Nigel M. Hooper, Anthony J. Turner, Ralph Hyde, Colin Dingwall, Ishrut Hussain, David L. Simmons, Frank S. Walsh, David Howlett and Thomas D. Meek and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Molecular Biology.

In The Last Decade

Gary Christie

25 papers receiving 3.8k citations

Hit Papers

A Human Homolog of Angiotensin-converting Enzyme 1999 2026 2008 2017 2000 1999 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary Christie United Kingdom 17 1.4k 1.4k 943 759 659 25 3.9k
David A. Sanan United States 32 1.6k 1.1× 2.1k 1.5× 358 0.4× 292 0.4× 445 0.7× 41 4.9k
Edward T. Parkin United Kingdom 25 1.0k 0.7× 1.3k 1.0× 256 0.3× 246 0.3× 211 0.3× 55 2.7k
Nathalie Cartier France 40 1.3k 0.9× 2.7k 2.0× 104 0.1× 150 0.2× 738 1.1× 87 4.5k
Anthony J. Turner United Kingdom 33 1.3k 0.9× 1.6k 1.2× 283 0.3× 244 0.3× 694 1.1× 90 3.3k
G. Enrico Rovati Italy 32 1.1k 0.7× 1.7k 1.2× 136 0.1× 531 0.7× 732 1.1× 107 3.8k
Guadalupe Sabio Spain 31 927 0.6× 2.5k 1.9× 258 0.3× 161 0.2× 268 0.4× 71 4.6k
Heinz Hillen Germany 20 1.4k 1.0× 1.1k 0.8× 187 0.2× 284 0.4× 306 0.5× 30 2.4k
Koji Yasojima Canada 22 1.1k 0.8× 898 0.7× 259 0.3× 432 0.6× 439 0.7× 30 3.1k
Lan Mao United States 39 687 0.5× 2.5k 1.9× 2.1k 2.3× 261 0.3× 389 0.6× 84 5.1k
Jamila Najïb France 18 1.3k 0.9× 3.9k 2.8× 357 0.4× 767 1.0× 275 0.4× 22 5.2k

Countries citing papers authored by Gary Christie

Since Specialization
Citations

This map shows the geographic impact of Gary Christie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Christie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Christie more than expected).

Fields of papers citing papers by Gary Christie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Christie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Christie. The network helps show where Gary Christie may publish in the future.

Co-authorship network of co-authors of Gary Christie

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Christie. A scholar is included among the top collaborators of Gary Christie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Christie. Gary Christie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heal, Jonathan R., Gareth W. Roberts, Gary Christie, & Andrew D. Miller. (2002). Inhibition ofβ-Amyloid Aggregation and Neurotoxicity by Complementary (Antisense) Peptides. ChemBioChem. 3(1). 86–92. 12 indexed citations
2.
Riddell, David, Gary Christie, Ishrut Hussain, & Colin Dingwall. (2001). Compartmentalization of β-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts. Current Biology. 11(16). 1288–1293. 259 indexed citations
3.
Karagiannis, Sophia N., K.H. Jennings, Paul R. Murdock, et al.. (2001). Endocytosis and recycling of the complex between CD23 and HLA‐DR in human B cells. Immunology. 103(3). 319–331. 57 indexed citations
4.
Hussain, Ishrut, Gary Christie, Klaus Schneider, Stephen E. Moore, & Colin Dingwall. (2001). Prodomain Processing of Asp1 (BACE2) Is Autocatalytic. Journal of Biological Chemistry. 276(26). 23322–23328. 30 indexed citations
5.
Bangs, James D., et al.. (2001). In vitro cytocidal effects on Trypanosoma brucei and inhibition of Leishmania major GP63 by peptidomimetic metalloprotease inhibitors. Molecular and Biochemical Parasitology. 114(1). 111–117. 28 indexed citations
6.
Prinjha, Rabinder, Stephen E. Moore, Mary Vinson, et al.. (2000). Inhibitor of neurite outgrowth in humans. Nature. 403(6768). 383–384. 461 indexed citations
7.
Hooper, Nigel M., et al.. (2000). A Human Homolog of Angiotensin-converting Enzyme. Journal of Biological Chemistry. 275(43). 33238–33243. 1599 indexed citations breakdown →
8.
Howlett, David, David L. Simmons, Colin Dingwall, & Gary Christie. (2000). In search of an enzyme: the β-secretase of Alzheimer's disease is an aspartic proteinase. Trends in Neurosciences. 23(11). 565–570. 48 indexed citations
9.
Hussain, Ishrut, David J. Powell, David Howlett, et al.. (2000). ASP1 (BACE2) Cleaves the Amyloid Precursor Protein at the β-Secretase Site. Molecular and Cellular Neuroscience. 16(5). 609–619. 131 indexed citations
10.
Ward, Robin V., K.H. Jennings, Davina E. OWEN, et al.. (2000). Fractionation and characterization of oligomeric, protofibrillar and fibrillar forms of β-amyloid peptide. Biochemical Journal. 348(1). 137–137. 31 indexed citations
11.
Assinder, Stephen J., Gary Christie, Grant Mason, et al.. (2000). Characterization of peptidyl boronic acid inhibitors of mammalian 20 S and 26 S proteasomes and their inhibition of proteasomes in cultured cells. Biochemical Journal. 346(2). 447–454. 43 indexed citations
12.
Assinder, Stephen J., Gary Christie, Grant Mason, et al.. (2000). Characterization of peptidyl boronic acid inhibitors of mammalian 20 S and 26 S proteasomes and their inhibition of proteasomes in cultured cells. Biochemical Journal. 346(2). 447–447. 7 indexed citations
14.
Hussain, Ishrut, David J. Powell, David Howlett, et al.. (1999). Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase. Molecular and Cellular Neuroscience. 14(6). 419–427. 887 indexed citations breakdown →
15.
Karran, Eric, David Allsop, Gary Christie, et al.. (1998). Presenilins – in search of functionality. Biochemical Society Transactions. 26(3). 491–496. 6 indexed citations
16.
Marolewski, Ariane E., Derek R. Buckle, Gary Christie, et al.. (1998). CD23 (Fc∊RII) release from cell membranes is mediated by a membrane-bound metalloprotease. Biochemical Journal. 333(3). 573–579. 35 indexed citations
17.
Allsop, David, David Howlett, Gary Christie, & Eric Karran. (1998). Fibrillogenesis of β-amyloid. Biochemical Society Transactions. 26(3). 459–463. 10 indexed citations
18.
Christie, Gary, A. D. Barton, Brian Bolognese, et al.. (1997). IgE secretion is attenuated by an inhibitor of proteolytic processing of CD23 (FcεRII). European Journal of Immunology. 27(12). 3228–3235. 39 indexed citations
19.
Heal, Jonathan R., et al.. (1997). Selektive Inhibierung von Interleukin‐1 durch Antisense‐Peptide. Angewandte Chemie. 109(9). 999–1004. 6 indexed citations
20.
Christie, Gary, et al.. (1995). Identification of a soluble, high affinity human interleukin 4 binding protein in normal human urine. Cytokine. 7(4). 305–310. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026